# Amphastar Pharmaceuticals, Inc.: Atropine Sulfate Injection shortage reverified (available from this maker)

**Score:** 35/100

| Field | Value |
|---|---|
| Manufacturer | Amphastar Pharmaceuticals, Inc. |
| Drug | Atropine Sulfate Injection |
| Dosage form | Injection |
| Therapeutic category | Anesthesia, Neurology, Pediatric |
| Status | Current |
| Stage | Shortage reverified (still listed) |
| Availability | Available |
| Presentations affected | 1 |
| Package NDCs | 76329-3340-1 |
| First posted | 2020-01-01 |
| Updated | 2026-10-16 |

## Why this score
- Sterile injectable: hospital and 503B demand.

Source: openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list) (https://dps.fda.gov/drugshortages). Last refreshed: 2026-11-04T06:10:12.565Z.
From the openFDA drug shortages endpoint, which mirrors the FDA drug shortage list and can lag it by days. Availability and recovery notes are the manufacturer's own statements to FDA. Company and product level only. Verify with FDA and the manufacturer before acting.